4-{(E)-2-[5-(3,5-dichlorophenyl)furan-2-yl]ethenyl}-6-(trifluoromethyl)pyrimidin-2(1H)-one

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-{(E)-2-[5-(3,5-dichlorophenyl)furan-2-yl]ethenyl}-6-(trifluoromethyl)pyrimidin-2(1H)-one
• 英文别名: 4-[(E)-2-[5-(3,5-dichlorophenyl)furan-2-yl]ethenyl]-6-(trifluoromethyl)-1H-pyrimidin-2-one
• 化学式: C₁₇H₉Cl₂F₃N₂O₂
• 分子量: 401.2
• InChiKey: ROBRWJXQMOGKHU-OWOJBTEDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  26
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  59.2
• 氢给体数：
  1
• 氢受体数：
  7

文献信息

• Pyrimidones with antiviral properties
  申请人：Axxima Pharmaceuticals Aktiengesellschaft

  公开号：EP1389461A1

  公开（公告）日：2004-02-18

  The present invention relates to vinylpyrimidine-2-one derivatives of the general formula (I): Furthermore the present invention relates to vinylpyrimidine-2-one derivatives and of the general formula (Ia): wherein R1 to R6 in formula (I) and in formula (Ia) represent independently of each other a variety of different substituents comprising alkyl, aryl, aralkyl, alkylaryl, heteroaryl groups and monofunctional moieties. The compounds are used as antivirals, especially against herpes and HCMV (Human Cytomegalovirus).

  本发明涉及一般式(I)的乙烯基嘧啶-2-酮衍生物，以及一般式(Ia)的乙烯基嘧啶-2-酮衍生物，其中在式(I)和式(Ia)中，R1至R6独立地表示各种不同的取代基，包括烷基，芳基，芳基烷基，烷基芳基，杂环芳基和单官能团。该化合物可用作抗病毒药物，特别是用于抗疱疹病毒和人类巨细胞病毒(HCMV)。
• Arf6 inhibitors and methods of synthesis and use thereof
  申请人：Navigen, Inc.

  公开号：US10849901B2

  公开（公告）日：2020-12-01

  Disclosed herein are compounds and methods for inhibiting Arf6. Pharmaceutical compositions and methods for treating a subject with an inhibitor of Arf6 are also disclosed herein.

  本文公开了抑制 Arf6 的化合物和方法。本文还公开了用 Arf6 抑制剂治疗受试者的药物组合物和方法。
• ARF6 INHIBITORS AND METHODS OF SYNTHESIS AND USE THEREOF
  申请人：Navigen, Inc.

  公开号：US20170189405A1

  公开（公告）日：2017-07-06

  Disclosed herein are compounds and methods for inhibiting Arf6. Pharmaceutical compositions and methods for treating a subject with an inhibitor of Arf6 are also disclosed herein.
• [EN] PYRIMIDONES AS ANTIVIRAL AGENTS<br/>[FR] PYRIMIDONES EN TANT QU'AGENTS ANTIVIRAUX
  申请人：AXXIMA PHARMACEUTICALS AG

  公开号：WO2004016271A1

  公开（公告）日：2004-02-26

  The present invention relates to vinylpyrimidine-2-one derivatives of general formula (I). Furthermore the present invention relates to vinylpyrimidine-2-one derivatives and of general formula (Ia), wherein R1 to R6 in formula (I) and in formula (Ia) represent independently of each other a variety of different substituents comprising alkyl, aryl, aralkyl, alkylaryl, heteroaryl groups and monofunctional moieties.